Idenix Pharmaceuticals to Present at the Third Annual JMP Securities Healthcare Focus Conference
September 29 2008 - 4:30PM
PR Newswire (US)
CAMBRIDGE, Mass., Sept. 29 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Idenix
management will present a corporate overview at the 2008 Third
Annual JMP Securities Healthcare Focus Conference on Monday,
October 6, 2008 at 4:00 p.m. ET at Le Parker Meridien in Manhattan.
The live and archived webcast of the company presentation can be
accessed under "Calendar of Events" in the Idenix Investor Center
at http://www.idenix.com/. Please log in approximately 5-10 minutes
before the event to ensure a timely connection. The archived
replays will be available on the Idenix website for weeks following
the conference. About Idenix Idenix Pharmaceuticals, Inc.,
headquartered in Cambridge, Massachusetts, is a biopharmaceutical
company engaged in the discovery and development of drugs for the
treatment of human viral and other infectious diseases. Idenix's
current focus is on the treatment of infections caused by the
hepatitis C virus and HIV. For further information about Idenix,
please refer to http://www.idenix.com/. Idenix Pharmaceuticals
Contacts: Amy Sullivan 617-995-9838 (investors) Teri Dahlman
617-995-9905 (media) DATASOURCE: Idenix Pharmaceuticals, Inc.
CONTACT: Amy Sullivan, investors, +1-617-995-9838, or Teri Dahlman,
media, +1-617-995-9905, both of Idenix Pharmaceuticals, Inc. Web
site: http://www.idenix.com/
Copyright
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024